Document is current
Any future updates will be listed below
-
Authors
Bae, Seongyeon S. https://orcid.org/0000-0002-4680-5301
Ling, Hsiang-Hsi https://orcid.org/0000-0002-1678-4845
Zhang, Jiankang
Chen, Yi https://orcid.org/0000-0002-4891-8289
Chen, Hong
Kumar, Dhiraj https://orcid.org/0000-0002-6085-5911
Saw, Ajay K.
Rai, Kunal https://orcid.org/0000-0003-2321-6894
Viny, Aaron D. https://orcid.org/0000-0001-7039-0110
DePinho, Ronald A. https://orcid.org/0000-0002-5625-577X
Giancotti, Filippo G. https://orcid.org/0000-0002-0541-9519
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35 CA197566)
- License Information
-
More Information
Article History
Received: 2 June 2025
Accepted: 11 May 2026
First Online: 22 June 2026
Competing interests
: R.A.D. is founder, advisor and/or director of Tvardi Therapeutics, Inc., Bectas Therapeutics, Inc. and Asylia Therapeutics, Inc. as well as a limited partner of Sporos Bioventures, LLC. The work of these entities is not related to the science of this manuscript. A.D.V. is on the scientific advisory board for Arima Genomics. The other authors declare no competing interests.
